本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Apellis Pharmaceuticals Inc.

17.42
-0.8400-4.60%
盘后17.420.00000.00%16:20 EDT
成交量:158.37万
成交额:2,776.44万
市值:21.89亿
市盈率:-9.70
高:18.24
开:18.03
低:17.35
收:18.26
数据加载中...
2025/07/01

重要事件披露

Form 8-K - Current report
2025/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/04

重要事件披露

Form 8-K - Current report
2025/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/21

重要事件披露

Form 8-K - Current report
2025/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities